![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » LOGICAL THERAPEUTICS, INC. IN-LICENSES NOVEL ANTI-INFLAMMATORY DRUG
LOGICAL THERAPEUTICS, INC. IN-LICENSES NOVEL ANTI-INFLAMMATORY DRUG
Logical Therapeutics, Inc. (Pittsburgh, PA) has entered into a licensing and collaboration agreement with Medinox, Inc. (Carlsbad, CA) for a novel non-steroidal anti-inflammatory agent (NSAID), to be known as LT-NS001.
Yahoo
Finance
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct